Open Letter: Urgent action necessary for equitable access to bedaquiline in all countries with high burdens of TB, MDR-TB, and TB/HIV

MSF Access Campaign, with other civil society organisations, signed onto this letter to Johnson & Johnson, calling on the pharmaceutical corporation not to enforce its secondary patents on the lifesaving TB drug bedaquiline.